JP2013544842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544842A5 JP2013544842A5 JP2013542143A JP2013542143A JP2013544842A5 JP 2013544842 A5 JP2013544842 A5 JP 2013544842A5 JP 2013542143 A JP2013542143 A JP 2013542143A JP 2013542143 A JP2013542143 A JP 2013542143A JP 2013544842 A5 JP2013544842 A5 JP 2013544842A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alkyl
- alkenyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HJPXILQMJHQFOX-UHFFFAOYSA-N CC(C)C(C1)C(C)C2C1C2C Chemical compound CC(C)C(C1)C(C)C2C1C2C HJPXILQMJHQFOX-UHFFFAOYSA-N 0.000 description 1
- BNYYSZJEZLQIFH-UHFFFAOYSA-N Cc(ccc(OCc1cccc(N)c1)c1)c1C(C(c1ccc(CC(O)=O)cc1C)=C)=O Chemical compound Cc(ccc(OCc1cccc(N)c1)c1)c1C(C(c1ccc(CC(O)=O)cc1C)=C)=O BNYYSZJEZLQIFH-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41911510P | 2010-12-02 | 2010-12-02 | |
| US61/419,115 | 2010-12-02 | ||
| PCT/US2011/062691 WO2012075174A2 (en) | 2010-12-02 | 2011-11-30 | Compounds and methods for skin repair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013544842A JP2013544842A (ja) | 2013-12-19 |
| JP2013544842A5 true JP2013544842A5 (enExample) | 2015-01-29 |
Family
ID=45316123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013542143A Pending JP2013544842A (ja) | 2010-12-02 | 2011-11-30 | 皮膚修復のための化合物および方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20120142684A1 (enExample) |
| EP (2) | EP3195863A1 (enExample) |
| JP (1) | JP2013544842A (enExample) |
| KR (1) | KR20130119958A (enExample) |
| CN (1) | CN103282033A (enExample) |
| AR (1) | AR084144A1 (enExample) |
| AU (1) | AU2011336582A1 (enExample) |
| BR (1) | BR112013015781A2 (enExample) |
| CA (1) | CA2819471A1 (enExample) |
| CL (1) | CL2013001579A1 (enExample) |
| MX (1) | MX2013006163A (enExample) |
| RU (1) | RU2013129262A (enExample) |
| SG (1) | SG190947A1 (enExample) |
| TW (1) | TW201307313A (enExample) |
| WO (1) | WO2012075174A2 (enExample) |
| ZA (1) | ZA201303949B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013003600A2 (pt) * | 2010-08-17 | 2016-08-16 | Allergan Inc | agonistas ep2 ou ep4 para o tratamento de névoa da córnea |
| US9005605B2 (en) * | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8889123B2 (en) * | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8883139B2 (en) * | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
| US8926963B2 (en) * | 2010-08-19 | 2015-01-06 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8900571B2 (en) * | 2010-08-19 | 2014-12-02 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| US8894992B2 (en) * | 2010-08-19 | 2014-11-25 | Allergan, Inc. | Compositions and soft tissue replacement methods |
| CA2891595A1 (en) * | 2012-11-16 | 2014-05-22 | Allergan, Inc. | Compounds and methods for skin repair |
| JP2016503422A (ja) * | 2012-11-16 | 2016-02-04 | アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | プロスタグランジンｅｐ４アゴニストの組み合わせを用いた皮膚創傷の治癒および瘢痕の減少 |
| ES2730895T3 (es) * | 2013-09-27 | 2019-11-13 | Allergan Inc | Compuestos y métodos para reparación cutánea |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| TWI249520B (en) * | 1998-07-15 | 2006-02-21 | Ono Pharmaceutical Co | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient |
| KR20010074981A (ko) * | 1998-09-14 | 2001-08-09 | 우에노 도시오 | ω치환된 페닐프로스타그란딘 Ｅ 유도체 및 그 유도체를유효 성분으로 하는 약제 |
| EP1408961B1 (en) * | 2001-07-16 | 2007-07-11 | F. Hoffmann-La Roche Ag | 2 pyrrolidone derivatives as prostanoid agonists |
| CN101921220B (zh) * | 2001-07-23 | 2013-05-22 | 小野药品工业株式会社 | 治疗与骨质损失有关的疾病的含有ep4激动剂作为活性成分的药物组合物 |
| US20040058313A1 (en) * | 2002-04-24 | 2004-03-25 | Abreu Marcio Marc | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| EP1563846B1 (en) * | 2002-10-10 | 2012-08-29 | Ono Pharmaceutical Co., Ltd. | Endogenous repair factor production promoters |
| BRPI0406717A (pt) * | 2003-01-10 | 2005-12-20 | Hoffmann La Roche | Composto, composição farmacêutica que compreende o mesmo, método de tratamento de uma enfermidade em um mamìfero, utilização do composto e processo para a sua produção |
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| US6875787B2 (en) | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| WO2005027931A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist |
| WO2006137472A1 (ja) * | 2005-06-24 | 2006-12-28 | Taisho Pharmaceutical Co., Ltd. | プロスタグランジン誘導体 |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
| US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
| NZ577109A (en) * | 2006-12-15 | 2011-12-22 | Glaxo Group Ltd | Benzamide derivatives as ep4 receptor agonists |
| EP2465506A1 (en) * | 2006-12-18 | 2012-06-20 | Allergan, Inc. | Methods and compositions for treating gastrointestinal disorders |
| WO2008092860A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| WO2008092861A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| WO2008092862A1 (en) * | 2007-01-30 | 2008-08-07 | Janssen Pharmaceutica N.V. | Bicyclic derivatives as ep4 agonists |
| GB0810615D0 (en) * | 2008-06-10 | 2008-07-16 | Glaxo Group Ltd | Novel pharmaceutical |
| US20110111031A1 (en) * | 2009-04-20 | 2011-05-12 | Guang-Liang Jiang | Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof |
| PH12013500205A1 (en) * | 2010-07-30 | 2017-08-23 | Allergan Inc | Compounds and methods for skin repair |
| WO2012024072A1 (en) * | 2010-08-19 | 2012-02-23 | Allergan, Inc. | Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition |
-
2011
- 2011-11-29 US US13/306,637 patent/US20120142684A1/en not_active Abandoned
- 2011-11-30 KR KR1020137017027A patent/KR20130119958A/ko not_active Withdrawn
- 2011-11-30 AU AU2011336582A patent/AU2011336582A1/en not_active Abandoned
- 2011-11-30 CN CN2011800627436A patent/CN103282033A/zh active Pending
- 2011-11-30 EP EP16198852.2A patent/EP3195863A1/en not_active Withdrawn
- 2011-11-30 SG SG2013042171A patent/SG190947A1/en unknown
- 2011-11-30 RU RU2013129262/15A patent/RU2013129262A/ru not_active Application Discontinuation
- 2011-11-30 JP JP2013542143A patent/JP2013544842A/ja active Pending
- 2011-11-30 WO PCT/US2011/062691 patent/WO2012075174A2/en not_active Ceased
- 2011-11-30 CA CA2819471A patent/CA2819471A1/en not_active Abandoned
- 2011-11-30 BR BR112013015781A patent/BR112013015781A2/pt not_active Application Discontinuation
- 2011-11-30 MX MX2013006163A patent/MX2013006163A/es unknown
- 2011-11-30 EP EP11794357.1A patent/EP2646017B1/en not_active Not-in-force
- 2011-12-02 AR ARP110104524A patent/AR084144A1/es unknown
- 2011-12-02 TW TW100144475A patent/TW201307313A/zh unknown
-
2013
- 2013-05-30 ZA ZA2013/03949A patent/ZA201303949B/en unknown
- 2013-05-31 CL CL2013001579A patent/CL2013001579A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536183A5 (enExample) | ||
| RU2013108394A (ru) | Соединения и способы восстановления кожи | |
| RU2013129262A (ru) | Соединения и способы для восстановления кожи | |
| RU2014113663A (ru) | Композиции кожного наполнителя для лечения мелких морщин | |
| JP2013517263A5 (enExample) | ||
| JP2017214429A5 (enExample) | ||
| KR102292206B1 (ko) | 티로신 유도체 및 이를 포함하는 조성물 | |
| KR20100098633A (ko) | 자색반병의 치료를 위한 조성물 및 방법 | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| RU2018106453A (ru) | Соединения | |
| RU2015116264A (ru) | Композиции и способы лечения сердечной недостаточности у пациентов с диабетом | |
| CN101972225A (zh) | 一种含吡非尼酮的凝胶组合物 | |
| JP6691119B2 (ja) | 爪甲真菌症の予防用または治療用の医薬組成物およびその製造方法 | |
| RU2014112324A (ru) | Применение органического соединения для лечения синдрома нунан | |
| JP2016514150A5 (enExample) | ||
| JP4393552B2 (ja) | ピリドンカルボン酸誘導体を含有するローション剤 | |
| JP2014530246A5 (enExample) | ||
| JP2015537028A5 (enExample) | ||
| JP2014517038A5 (enExample) | ||
| JP2015537028A (ja) | 皮膚修復のための組成物および方法 | |
| CN106267172A (zh) | 一种用于预防瘢痕的组合物及其制备方法和应用 | |
| JP2018534358A (ja) | Ｖｅｇｆ阻害剤の局所投与による皮膚障害の処置 | |
| EA201890714A1 (ru) | Композиция для лечения бесплодия у субъекта женского пола | |
| JP2017528517A (ja) | 多汗症を治療するための方法 | |
| US20230372583A1 (en) | Compositions and methods for treating facial volume defects |